Next Article in Journal
Pharmacokinetic Evaluation of Oral Viscous Budesonide in Paediatric Patients with Eosinophilic Oesophagitis in Repaired Oesophageal Atresia
Next Article in Special Issue
Enrofloxacin Pharmaceutical Formulations through the Polymer-Free Electrospinning of β-Cyclodextrin–oligolactide Derivatives
Previous Article in Journal
IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma
Previous Article in Special Issue
Polymer-Drug Anti-Thrombogenic and Hemocompatible Coatings as Surface Modifications
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(7), 871; https://doi.org/10.3390/pharmaceutics16070871
Action Date Notes Link
article pdf uploaded. 28 June 2024 17:33 CEST Version of Record https://www.mdpi.com/1999-4923/16/7/871/pdf-vor
article xml file uploaded 10 July 2024 12:08 CEST Original file -
article xml uploaded. 10 July 2024 12:08 CEST Update -
article pdf uploaded. 10 July 2024 12:08 CEST Updated version of record https://www.mdpi.com/1999-4923/16/7/871/pdf-vor
article html file updated 10 July 2024 12:09 CEST Original file -
article xml file uploaded 26 July 2024 10:52 CEST Update -
article xml uploaded. 26 July 2024 10:52 CEST Update https://www.mdpi.com/1999-4923/16/7/871/xml
article pdf uploaded. 26 July 2024 10:52 CEST Updated version of record https://www.mdpi.com/1999-4923/16/7/871/pdf
article html file updated 26 July 2024 10:56 CEST Update https://www.mdpi.com/1999-4923/16/7/871/html
Back to TopTop